Autism Spectrum Disorder Trial, Recruiting (NCT07216196)

Autism Spectrum Disorder Trial, Recruiting NCT07216196 Sponsor: University of Missouri-Columbia Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT07216196 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Autistic adolescents between the ages of 13 and 21, along with one parent, guardian, or caregiver who is 18 years or older
The adolescent must have at least one year left in high school
The adolescent must be able to hold a back-and-forth conversation
The adolescent must be able to give their agreement to participate through a specially designed process that protects their rights and avoids pressure, whether or not they have an intellectual disability

Who may not be able to join:

Adolescents with a severe or profound intellectual disability (generally meaning an IQ score below 35)
Adolescents with serious mental health conditions that would make it difficult to take part in the program
Adolescents who are already receiving community transition support services that overlap significantly with what this trial offers

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Melanie M. Tkach, PhD, University of Missouri-Columbia

Phone: 573-882-0992

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07216196

Sponsor: University of Missouri-Columbia

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 573-882-0992

More information: https://clinicaltrials.gov/study/NCT07216196

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Autistic adolescents between the ages of 13 and 21, along with one parent, guardian, or caregiver who is 18 years or older
The adolescent must have at least one year left in high school
The adolescent must be able to hold a back-and-forth conversation
The adolescent must be able to give their agreement to participate through a specially designed process that protects their rights and avoids pressure, whether or not they have an intellectual disability

Who may not be able to join:

Adolescents with a severe or profound intellectual disability (generally meaning an IQ score below 35)
Adolescents with serious mental health conditions that would make it difficult to take part in the program
Adolescents who are already receiving community transition support services that overlap significantly with what this trial offers

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Missouri-Columbia

Registry

ClinicalTrials.gov

Start date

8 April 2026

Est. completion

3 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability of Intervention Measure (AIM); Semi-Structured Interview

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov